On September 7, 2021 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that HOOKIPA’s management team will participate and present at the following upcoming virtual investor conferences (Press release, Hookipa Pharma, SEP 7, 2021, View Source [SID1234587286]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference, September 9 – 10 and 13 – 15, 2021
Fireside Chat: September 10, 8:45am ET
H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021
Presentation: September 13, 7:00am ET
2021 Cantor Virtual Global Healthcare Conference, September 27 – 30, 2021
Presentation: September 28, 8:00-8:30am ET in Track 7
Webcasts will be available within the Investors & Media section of HOOKIPA’s website at View Source Archived replays will be accessible for 30 days following each event.